MSI2 and non-small cell lung carcinoma: Depletion of MSI2 in CAFs not only impaired its own cell motility (Fig. 2E; Additional file 2: Fig. S7) but also inhibited NSCLC cell motility, in part, through a paracrine signaling (Fig. 2D).